Following the positive opinion received on November 24th from the French regulatory authority ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé) in the treatment of lateral

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

Existing Users Log In